NANOMEDICINE

The Nanomedicine Workshop offers a unique and engaging forum for medical professionals, scientists, engineers, and industry stakeholders from various fields, to acquire up-to-date knowledge on Nanomedicine advancements related to Biomedical Engineering, Biomedicine, Nanomaterials and Clinical Applications. It aims to offer a forum for academia and industry around the world, to network across the ecosystem, to foster partnerships and showcase state-of-the-art scientific and technological advancements in Nanomedicine.

The workshop provides participants the opportunity to gain valuable insights from invited keynote speakers who possess expert knowledge on worldwide innovation trends and the science of nanomedicine, thereby facilitating the convergence of Nanosciences-Nanotechnologies with clinical practice. The scientific program will include comprehensive talks, special sessions, debates, oral and poster presentations of peer-reviewed contributions, that highlights the most recent breakthroughs in various fields of Nanomedicine.

The Workshop will address progress and prospects for nanomedicine including, Nanotoxicology, Biomedical Engineering, Nanobiotechnology, Pharmaceutical Nanotechnology, Nanoparticles and Molecular Nanotechnology, Regenerative Medicine, Cancer Nanomedicine, updates on Preclinical & Clinical Trials and Regulations.

Together with the co-located Bioelectronics Workshop, it will provide the latest advances in biosensors and bioactuators from bench to bedside. Fundamentals of biosensor design and manufacturing will be covered and translated into clinical applications.

The Nanomedicine Workshop covers (but not limited to) the following key topics:

Basics related to Medicine, Biology, and Nanotechnology

• Biological Systems and Biological Structures
• Biomedical Engineering & Nanobiotechnology
• Nanotechnology for Health products
• Cell/Nanomaterial Interactions & Cellular-Level Interventions
• Biomechanics

Nanobiomedicine

• Theranostics
• Nanotoxicology
• Nanoinformatics
• Clinical Nanomedicine
• Nanovaccines and Immunotherapy
• Nanomedicine-based cancer immunotherapy
• Stimuli-responsive nanosystems

Nanomaterials for Bio-Applications

• Nanostructures for medical applications
• Biomaterials and Bio-Nano Interface
• Nanoparticles & Nanosystems for Health care

Clinical Applications

• Biomaterials and Nanomaterials for biosensing, imaging, diagnostic and vectorization
• In-vivo Diagnostics, Imaging & Therapy
• Nanosurgery: Precision Instruments & Nanorobotics
• Drug Delivery Systems (DDS)
• Tissue engineering & Regenerative Nanomedicine
• Nanoparticles and Molecular Nanotechnology
• Nanodrugs and Pharmaceutical Nanotechnology
• Nano-Cosmetics
• Nanodentistry
• Nanomedicine Targeting Major and Chronic Diseases
• Clinical Translation and Regulations

Update on Preclinical and Clinical trials on Nanomedicine

Nanotoxicity, Risk Assessment and Ethics

Commercialization in Nanomedicine

Special Session on Applying nanosafety competencies to the Advanced Materials arena

Thursday, July 10th, 2025, 9:00-13:00

This workshop organized by the Network for Safety and sustainability of Chemicals and materials (NSC), intends to connect the successful work of more than a decade of nanosafety research with the needs and requirements of nowadays arena of Advanced/innovative Materials (AdMa). Applying nanosafety competencies to the AdMa arena involves integrating safety protocols and risk assessment strategies to manage the potential hazards associated with nanomaterials (NMs). This includes understanding the unique properties of NMs, such as their size, shape, and reactivity, which can pose different risks compared to bulk materials. By leveraging nanosafety expertise, researchers and manufacturers can develop safer AdMa, ensuring they are safe for both human health and the environment. This proactive approach helps in mitigating risks, promoting sustainable development, and fostering innovation in the field of AdMa.

The session will be divided in two parts

First part (9:00-11:00)

Keynote presentation by Prof. Eva Valsami-Jones, University of Birmingham, UK
"From nanomaterials to advanced materials and their safe and sustainable future"

followed by presentations on
"Governance and policy aspects towards safety and sustainability of AdMa"
"The Advanced Materials ecosystem – enabling synergies with cross-sectorial collaboration"
and oral presentations from other participants

Second part (11:30-13:00)

Project-related presentations in the style of pitches e.g. from early career researchers (ECRs).

Supported by

Special Session on Law and ethics of nanotechnology safety and health: NANOMEDICINE TRANSFORMING Disability INTO Health

Dedicating a science conference session to Law and Ethics represents an important recognition by researchers of their need to learn about and participate as stakeholders in nanotechnology law and ethics programming. The session's focus on safety and health represents Nanomedicine as a game changer under law-- A deep dive into discussing what that means for scientific researchers, lawyers and society.

• Vasiliki Papadouli, Post-Doc, Vrije Universiteit Brussel
  Legal and ethical challenges raised for modern physicians by disruptive technologies
• Dr. Cagrı Zeybek Unsal, Hacettepe University Faculty of Medicine (History of Medicine and Medical Ethics, Bioethics Center)
  Stem cell research legislation of 19 countries
• Silke Krol, encytos BV, Enschede, The Netherlands
  Nanomedicine:Legal and ethical challenges
• Prof. Angelos Kornilakis, Faculty of Law, AUTH, Greece
  ΑΙ as caretaker and companion- ethical and legal personality aspects
• Dr. Vassara Chrisa, Agios Loukas Hospital, Researcher AUTh, Greece
  Nanorobots in the Human Bloodstream: Ethical Dilemmas
• Session Chair Dr Ilise Feitshans, JD and ScM and DIR, President Virginia Mountain Valley Lawyers Alliance Specialty Bar, Roanoke Virginia and Expert, O'Neill Institute for National and Global Health Law, Georgetown University Law Center Class of 2025
  You Wear It Well: wearable electronics as a Game changer for EMS providers and High Risk Patients

 

WORKSHOP 3 COMMITTEE (tentative)

V. Karagkiozaki, Dep. of Physics, Aristotle University of Thessaloniki and Lifestyle Medicine Clinic, Greece
T. Mitsiadis, Uni of Zurich, Switzerland
N. Baldini, Uni of Bologna and Istituto Ortopedico Rizzoli, Italy
L. P. Balogh, Precision Nanomedicine, USA
M. Buehler, Massachusetts Institute of Technology, USA
E. Chang, Dept of Oncology, Lombardi Comprehensive Cancer Center, Georgetown Uni, USA
Th. Choli – Papadopoulou, Chemistry Dept, AUTh, Greece
H. Hosseinkhani, Innovation Center for Advanced Technology, Matrix, Inc., USA
J. R. Kanwar, All India Institute of Medical Sciences Bhopal, India
G. Kousoulas, Division of Biotechnology & Molecular Medicine, Louisiana State Uni, USA
M. Masserini, Medical School- Uni of Milan Bicocca, Italy
H. J. Meisel, Department of Neurosurgery, BG-Clinic Bergmannstrost, Germany
A. Mikos, Rice Uni, USA
Y. Missirlis, Lab of Biomechanics & Biomedical Engineering, Uni of Patras, Greece
D. Paolino, University "Magna Graecia" of Catanzaro, Italy
M. Stevens, Imperial College London, UK
S. Sunoqrot, Al-Zaytoonah University, Jordan
M. Tanaka, Kyushu Uni & Uni of Yamagata, Japan

 

---

Organized by:

	EU H2020-FlexFunction2Sustain: "Open Innovation Ecosystem for Sustainable Nano-functionalized Flexible Plastic and Paper Surfaces and Membranes" www.flexfunction2sustain.eu

Supported by: